Sudhir Srivastava: I consider myself as an early adopter of AI/ML and the technological development in this area
Sudhir Srivastava, Senior Scientific Officer of Cancer Biomarkers Research at National Cancer Institute (NCI), shared in LinkedIn:
“AI/ML has become a buzz word these days. I remember hosting a NCI-sponsored workshop in early 1994 on Computer Applications in Early Detection and Staging of Cancer and the entire proceeding was published in the journal Cancer Letters See below). I consider myself as an early adopter of AI/ML and the technological development in this area. AI/ML is increasingly being used in diagnostic resolution. I am so fortunate to see the revolution in technological advancements in a variety of applications. Let us focus our energy toward fulfilling the dream of early cancer detection and curative treatment.”
Source: Sudhir Srivastava/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023